# FDA recall D-0231-2016

> **Akorn, Inc.** · Class III · drug recall initiated 2015-08-20.

## Product

RIFAMPIN FOR INJECTION USP, 600 mg*/vial, Rx Only. Mfd. for: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-151-42.

## Reason for recall

Failed Impurity/Degradation Specifications:  Out of Specifications result obtained for a known impurity.

## Distribution

US: Nationwide

## Key facts

- **Recall number:** D-0231-2016
- **Recalling firm:** Akorn, Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2015-08-20
- **Report date:** 2015-11-25
- **Termination date:** 2017-01-26

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0231-2016

## Citation

> AI Analytics. FDA recall D-0231-2016. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-0231-2016. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*